Terms: = Bone cancer AND FIP1L1, DKFZp586K0717, 81608, ENSG00000145216, Q6UN15 AND Diagnosis
9 results:
1. Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneity.
Zhao M; Wu Q; Xia L; Zhang M; Yang J; Li Y; Tu S; Wang Y
Cancer Biol Ther; 2019; 20(4):402-407. PubMed ID: 30359545
[TBL] [Abstract] [Full Text] [Related]
2. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation.
Schwaab J; Jawhar M; Naumann N; Schmitt-Graeff A; Fabarius A; Horny HP; Cross NC; Hofmann WK; Reiter A; Metzgeroth G
Ann Hematol; 2016 Mar; 95(4):557-62. PubMed ID: 26797429
[TBL] [Abstract] [Full Text] [Related]
4. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
Zhou J; Papenhausen P; Shao H
Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
[TBL] [Abstract] [Full Text] [Related]
5. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics of cytogenetics and molecular biology in patients with eosinophilia].
Qu SQ; Ai XF; Li CW; Li QH; Xu ZF; Qin TJ; Zhang Y; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1216-20. PubMed ID: 23114151
[TBL] [Abstract] [Full Text] [Related]
7. [Myeloproliferative neoplasms: histopathological and molecular pathological diagnosis].
Hussein K; Büsche G; Schlue J; Lehmann U; Kreipe H
Pathologe; 2012 Nov; 33(6):508-17. PubMed ID: 23085694
[TBL] [Abstract] [Full Text] [Related]
8. t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia.
Wang HY; Thorson JA; Broome HE; Rashidi HH; Curtin PT; Dell'Aquila ML
Hum Pathol; 2011 Dec; 42(12):2029-36. PubMed ID: 21676437
[TBL] [Abstract] [Full Text] [Related]
9. PDGFRalpha/fip1l1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment.
Vigna E; Lucia E; Gentile M; Mazzone C; Bisconte MG; Gentile C; Armentano A; Ottaviani E; Rondoni M; Martinelli G; Morabito F
Cancer Chemother Pharmacol; 2008 Apr; 61(4):713-6. PubMed ID: 17549478
[TBL] [Abstract] [Full Text] [Related]